GOLDMAN SACHS GROUP INC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$319,422
+25.8%
185,711
+42.6%
0.00%
Q2 2023$253,935
-66.9%
130,223
-52.8%
0.00%
Q1 2023$766,627
+78.0%
275,765
+120.9%
0.00%
Q4 2022$430,670
+35.0%
124,832
+0.6%
0.00%
Q3 2022$319,000
-15.6%
124,086
-20.5%
0.00%
Q2 2022$378,000
-68.3%
156,015
-46.2%
0.00%
Q1 2022$1,194,000
-79.0%
289,897
-34.4%
0.00%
-100.0%
Q4 2021$5,681,000
+736.7%
441,761
+603.2%
0.00%
Q3 2021$679,000
+121.2%
62,825
+86.6%
0.00%
Q2 2021$307,000
-65.0%
33,665
-63.8%
0.00%
Q1 2021$877,000
+492.6%
93,050
+147.2%
0.00%
Q4 2020$148,000
-25.3%
37,635
-49.8%
0.00%
Q3 2020$198,000
-22.0%
74,942
+95.6%
0.00%
Q2 2020$254,000
+84.1%
38,307
+61.6%
0.00%
Q1 2020$138,000
-45.2%
23,711
-15.7%
0.00%
Q4 2019$252,000
+113.6%
28,122
+105.0%
0.00%
Q3 2019$118,000
-6.3%
13,716
+21.1%
0.00%
Q2 2019$126,000
-97.0%
11,324
-96.2%
0.00%
-100.0%
Q3 2018$4,211,000295,7110.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders